EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $67,896,000 | -37.0% | 4,377,518 | 0.0% | 3.55% | -30.3% |
| Q4 2019 | $107,687,000 | +138.5% | 4,377,518 | 0.0% | 5.09% | +36.2% |
| Q3 2019 | $45,154,000 | -17.8% | 4,377,518 | 0.0% | 3.74% | -2.9% |
| Q2 2019 | $54,938,000 | -35.5% | 4,377,518 | -36.4% | 3.85% | -13.0% |
| Q1 2019 | $85,212,000 | +101.1% | 6,877,518 | 0.0% | 4.42% | +163.3% |
| Q4 2018 | $42,366,000 | -38.1% | 6,877,518 | +6.4% | 1.68% | -43.1% |
| Q3 2018 | $68,485,000 | -21.8% | 6,460,851 | 0.0% | 2.96% | -27.9% |
| Q2 2018 | $87,545,000 | -23.7% | 6,460,851 | 0.0% | 4.10% | -19.6% |
| Q1 2018 | $114,680,000 | +41.4% | 6,460,851 | 0.0% | 5.10% | +51.9% |
| Q4 2017 | $81,084,000 | -34.1% | 6,460,851 | 0.0% | 3.36% | -22.1% |
| Q3 2017 | $123,079,000 | +30.2% | 6,460,851 | +3.2% | 4.31% | +25.3% |
| Q2 2017 | $94,539,000 | -12.0% | 6,260,851 | 0.0% | 3.44% | -7.9% |
| Q1 2017 | $107,374,000 | +41.7% | 6,260,851 | 0.0% | 3.73% | +24.0% |
| Q4 2016 | $75,756,000 | +23.0% | 6,260,851 | 0.0% | 3.01% | +8.9% |
| Q3 2016 | $61,607,000 | -3.9% | 6,260,851 | 0.0% | 2.76% | -16.9% |
| Q2 2016 | $64,111,000 | -15.5% | 6,260,851 | 0.0% | 3.33% | -34.0% |
| Q1 2016 | $75,882,000 | -8.0% | 6,260,851 | +21.6% | 5.04% | -4.0% |
| Q4 2015 | $82,499,000 | +24.6% | 5,149,740 | 0.0% | 5.25% | +20.4% |
| Q3 2015 | $66,226,000 | -46.4% | 5,149,740 | 0.0% | 4.36% | -32.4% |
| Q2 2015 | $123,594,000 | +27.8% | 5,149,740 | 0.0% | 6.45% | +47.6% |
| Q1 2015 | $96,712,000 | -0.5% | 5,149,740 | 0.0% | 4.37% | -7.2% |
| Q4 2014 | $97,176,000 | -30.4% | 5,149,740 | 0.0% | 4.71% | -33.6% |
| Q3 2014 | $139,609,000 | -30.4% | 5,149,740 | -20.1% | 7.10% | -24.6% |
| Q2 2014 | $200,602,000 | +36.7% | 6,446,089 | 0.0% | 9.41% | +30.6% |
| Q1 2014 | $146,777,000 | +9.5% | 6,446,089 | 0.0% | 7.21% | +11.2% |
| Q4 2013 | $134,079,000 | -44.5% | 6,446,089 | +6.7% | 6.48% | -32.3% |
| Q3 2013 | $241,584,000 | +42.2% | 6,039,589 | 0.0% | 9.57% | +26.1% |
| Q2 2013 | $169,894,000 | – | 6,039,589 | – | 7.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |